STERIS plc
STE · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.58 | 0.22 | -3.12 | -2.09 |
| FCF Yield | 3.48% | 2.81% | 2.07% | 1.68% |
| EV / EBITDA | 17.94 | 17.71 | 16.45 | 26.27 |
| Quality | ||||
| ROIC | 7.17% | 6.42% | 6.44% | 3.47% |
| Gross Margin | 44.01% | 43.17% | 43.66% | 44.59% |
| Cash Conversion Ratio | 1.86 | 2.56 | 7.15 | 2.82 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.37% | 6.76% | 13.44% | 11.69% |
| Free Cash Flow Growth | 26.93% | 55.19% | -0.57% | -11.80% |
| Safety | ||||
| Net Debt / EBITDA | 1.49 | 2.25 | 2.26 | 2.90 |
| Interest Coverage | 10.05 | 5.79 | 7.14 | 5.34 |
| Efficiency | ||||
| Inventory Turnover | 5.26 | 4.33 | 4.23 | 4.07 |
| Cash Conversion Cycle | 105.68 | 124.46 | 118.20 | 123.53 |